1 not yet recruiting, 1 recruiting, 1 withdrawn. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Not yet recruiting 1, Recruiting 1, Withdrawn 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow B-Acute Lymphoblastic Leukemia: new trials by email Literature Review of B-Acute Lymphoblastic Leukemia trials Research Report on B-Acute Lymphoblastic Leukemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pre-emptive Anakinra for Cytokine Event Reduction Anakinra (Kineret®) - B-Acute Lymphoblastic Leukemia, CAR-T Cell Therapy | Phase 1 / Phase 2 | Withdrawn | Kevin McNerney | 2026-10-01 | 2026-08-13 | |
| Evaluation of the Safety and Efficacy of Sup19 CAR-T Cells in Patients With Previously Failed CD19-Targeted Therapy or CD19-Weakly Expressed Hematologic Tumors Sup19 CAR-T - B-Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia/Lymphoma | Phase 1 | Not yet recruiting | Institute of Hematology & Blood Diseases Hospital, China | 9 | 2026-04-01 | 2026-04-20 |
| In VIVO CAR-T Therapy for Relapsed/Refractory Hematological Malignancies Invivo CAR-T - B-Acute Lymphoblastic Leukemia, B Cell Non-Hodgkin's Lymphoma | Phase 1 | Recruiting | Chongqing Precision Biotech Co., Ltd | 24 | 2025-07-01 | 2025-11-20 |
Burkitt Lymphoma (3) · Cytokine Release Syndrome (1) · Lymphoma (1) · Lymphoma, B-Cell (1) · Multiple Myeloma (1)
DNA Virus Infections (3) · Epstein-Barr Virus Infections (3) · Hemic and Lymphatic Diseases (3) · Herpesviridae Infections (3) · Immune System Diseases (3) · Immunoproliferative Disorders (3) · Infections (3) · Lymphatic Diseases (3) · Lymphoma, Non-Hodgkin (3) · Lymphoproliferative Disorders (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Tumor Virus Infections (3) · Virus Diseases (3) · Lymphoma (2)
Interleukin 1 Receptor Antagonist Protein (1)
Chongqing Precision Biotech Co., Ltd (1) · Institute of Hematology & Blood Diseases Hospital, China (1) · Kevin McNerney (1)
China (2) · United States (1)
Wang Sanbin, MD (1)
K12TR005104 (1)